Patrick Campbell

Pharmacosmos Therapeutics Inc. announced the FDA granted approval of ferric derisomaltose injection for the treatment of iron deficiency anemia.

New data from the Annual Meeting of the Society of Thoracic Surgeons reveals a three-day stay is not associated with increased risk of worse outcomes or readmission.

A new analysis of more than 125,000 found no differences in mortality or MACE based on type of insulin used.

New data suggests sacubitril/valsartan could reduce risk of hospitalization and mortality in HFrEF patients when compared with ACEs/ARBs.

A new review of more than a dozen studies is breaking down racial differences in diagnosis, treatment, and outcomes of severe aortic stenosis.

Functional disability or death rates 3 months following intracerebral hemorrhage are notably less among 2 minority groups.

A new study is warning a common practice when it comes to recording blood pressure could be ignoring a potential warning sign for risk later in life.

A new study is shedding light on the potential impact of medical marijuana on sleep quality in patients who suffer from chronic pain, regardless of pain levels and other medication use.

As out-of-pocket costs increased, the number of pediatric primary care visits began to plummet.

A new review in the Journal of the American College of Cardiology is highlighting the impact of marijuana use on heart health.

Analysis of more than 20,000 individuals found excess belly fat—measured by waist circumference—was linked to a significantly increased risk for suffering recurrent ASCVD events.

The latest episode of the DocTalk Podcast features Tsuyoshi Kaneko, MD, of Brigham and Women's Hospital, discussing the most recent data and trends in transcatheter aortic valve replacement.

New data from a Duke University study suggests virtual physical therapy could slash costs without sacrificing the efficacy of an in-person program.

Contrary to current guidelines, a recent study has found performing surgery before aortic stenosis patients become symptomatic could dramatically improve outcomes

New research suggests Abbott's HeartMate 3 could revolutionize preimplantation strategy by eliminating use of categories based on transplant eligibility.

After FDA committees vote 27-0 against recommending the NDA for NKTR-181, Nektar Therapeutics announced they were withdrawing the application and canceling the program.

Less than 1 in 4 eligible Medicare patients attend a cardiac rehabilitation program and, among participants, adherence to programs remains an issue.

A recent analysis of ARIC study data found burnout is associated with a 1.45-fold increased risk of developing the cardiac condition.

Despite it being the preferred treatment in guidelines, ticagrelor was linked with more major bleeding and dyspnea than clopidogrel.

Approval of Aidoc's AI package could improve diagnosis and subsequent outcomes for stroke in emergency departments.

An expecting mother's use of antihypertensive medication may affect their risk of having a preterm birth, new findings show.

A recent analysis of participants in the NHANES database found low fat and Mediterranean diets were linked to lower serum testosterone levels in men.

An analysis of more than 9000 patients found incident heart disease was associated with an increased risk of developing kidney failure later in life.

A pilot study from the University of Warwick found sitagliptin, which is approved for glycemic control in diabetics, could be a promising treatment for reducing miscarriages in women with recurrent pregnancy loss.

Results of the Canadian CANTREAT study are debunking the notion anti-VEGF injections with ranibizumab need to take place monthly as opposed to a treat-and-extend regimen.

A new study has found habitual tea drinkers lowered their risk of atherosclerotic cardiovascular disease, coronary heart disease, and stroke compared to never or non-habitual tea drinkers.

An analysis of the CARDIA study revealed BMI in young adulthood served as a better predictor of obesity up to 25 years in the future than polygenic risk scores.

A recent study found a lower blood pressure target in older adults could reduce risk of cardiovascular events and death, but could negatively impact kidney function.

Abbot announced early Tuesday morning that the US FDA has granted approval for the HeartMate 3 device to be implanted via a lateral thoracotomy for patients with advanced heart failure.

A new study examining rates of venous thromboembolism revealed children receiving PICCs as opposed to CVCs were at an increased risk of blood clots.